The Global Desktop-Based Spirometer Market was valued at USD 522.72 million and is projected to reach a market size of USD 884.30 million by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 7.8%.
The medical device market sector that deals with spirometry equipment made to be utilized on a desk or table top is known as the desktop-based spirometer market. Spirometry is a medical test that assesses a person's capacity for breathing in and out, as well as how rapidly they can do so. Healthcare practitioners utilize desktop-based spirometers to diagnose and track respiratory disorders like asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis in clinics, hospitals, and other medical settings. Due to factors like the rising geriatric population, rising geriatric prevalence, technological advancements in spirometry devices, and rising awareness about early diagnosis and treatment of respiratory conditions, the global market for desktop-based spirometers is anticipated to expand in the upcoming years. The adoption of telemedicine and remote patient monitoring, which enables patients to do spirometry tests at home and send the findings to their healthcare professionals for analysis, is another factor driving the market. They are also offered for home usage, enabling patients to routinely keep an eye on their lung function. To ensure accurate results and good data interpretation, spirometry testing should, however, always be overseen by a qualified healthcare expert.
Global Desktop-Based Spirometer Market Drivers:
The market is expanding as a result of the creation of cutting-edge software and technology for desktop-based spirometers. Spirometry testing is becoming more accurate and effective due to new technologies including wireless networking, cloud-based data storage, and real-time data processing:
Demand for spirometry testing is being driven by the increased prevalence of respiratory illnesses such as asthma, COPD, and cystic fibrosis. Desktop-based spirometers are a crucial tool for identifying and treating respiratory problems because they provide accurate and dependable testing. The market is expanding as a result of the creation of cutting-edge software and technology for desktop-based spirometers. Spirometry testing is becoming more accurate and effective thanks to new technologies including wireless networking, cloud-based data storage, and real-time data processing. The demand for mobile and user-friendly desktop-based spirometers is being driven by the growing trend toward home healthcare. Patients can regularly check their lung function via home spirometry testing, which eliminates the need for frequent trips to medical institutions.
Government Initiatives and Funding for Spirometry Equipment Development is driving market growth:
The market for desktop-based spirometers is expanding as a result of increased healthcare costs in both developed and developing nations. To enhance patient outcomes and lower healthcare costs, healthcare providers are investing in cutting-edge spirometry equipment. Governments all across the world are putting plans into action to enhance respiratory health and lessen the impact of respiratory disorders. These programs include support for the development of cutting-edge spirometry equipment, which is fuelling the market's expansion.
Global Desktop-Based Spirometer Market Challenges:
Spirometry tests must be administered and findings interpreted by qualified medical specialists. In many areas, there is a severe dearth of qualified healthcare workers, which restrains industry expansion. The cost of desktop-based spirometers may be prohibitive for patients and healthcare professionals. The widespread use of spirometry testing may be constrained by the expensive cost of equipment, particularly in poor nations. Spirometry testing has several advantages, but many patients and medical professionals are unaware of these advantages or how to effectively do the test. Inaccurate testing and incorrect findings interpretation might be caused by a lack of education and awareness, which can restrain market expansion.
Global Desktop-Based Spirometer Market Opportunities:
The need for desktop-based spirometers is being driven by the expanding use of telemedicine and remote patient monitoring. Healthcare professionals can more effectively monitor patient lung function and treat respiratory illnesses because of the ability to do spirometry testing remotely. The need for spirometry testing is being driven by the growing emphasis on preventative healthcare and early diagnosis of respiratory illnesses. Spirometers that are desktop-based are an indispensable component of preventive healthcare since they provide accurate and dependable testing. The market for desktop-based spirometers has a lot of room to grow due to the rising demand for spirometry testing in developing regions like Asia Pacific and Latin America. The demand for spirometry testing is being driven by the increasing prevalence of respiratory illnesses in these areas.
COVID-19 Impact on Global Desktop-Based Spirometer Market:
Spirometry testing has seen a large surge in demand as a result of the COVID-19 outbreak. Spirometry testing has been used by medical professionals to monitor COVID-19 patients and assess lung function following recovery. Spirometry testing is one of the elective procedures that has been delayed as a result of the COVID-19 epidemic. Spirometry testing demand has decreased as a result of numerous healthcare facilities delaying non-essential operations to lower the risk of COVID-19 transmission. Due to the COVID-19 pandemic's disruption of global supply systems, spirometry tools, and supplies are in limited supply. Spirometry testing has become more expensive as a result of supply chain interruption and price rises.
Global Desktop-Based Spirometer Market Recent Developments:
In October 2022, The VyntusTM WALK, a mobile desktop-based spirometer that enables users to conduct spirometry testing while walking, was introduced by Vyaire Medical.
DESKTOP-BASED SPIROMETER MARKET REPORT COVERAGE:
REPORT METRIC |
DETAILS |
Market Size Available |
2022 - 2030 |
Base Year |
2022 |
Forecast Period |
2023 - 2030 |
CAGR |
7.8% |
Segments Covered |
By Technology, Application, End-User and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
Key Companies Profiled |
CareFusion Corporation, CHEST M.I., Inc., Cosmed srl, Futuremed America Inc., MGC Diagnostics Corporation, ndd Medical Technologies, Inc., NIHON KOHDEN CORPORATION, Schiller AG, Medical International Research, Vitalograph, Welch Allyn, SDI Diagnostics, Fukuda Sangyo Co., Ltd., Vyaire Medical, Inc. |
Volume Measurement
Flow Measurement
Peak Flow Measurement
In 2022, the flow measurement segment held the highest market share and dominated the market holding a share of around 66.7%. This is due to its wide-scale applications in pulmonary function testing. These devices are typically based on table top technology and have no moving parts, which makes them convenient to handle. The peak flow measurement segment is estimated to witness the maximum growth at around a 10.9% growth rate during the outlook period from 2022 to 2030.
Diagnostic Applications
Therapeutic Applications
Asthma, chronic obstructive pulmonary disease (COPD), and bronchitis are some of the respiratory conditions that can be diagnosed by diagnostic spirometry testing. Spirometry testing is also used to screen for occupational lung disorders and to evaluate the effectiveness of medicines, as well as to measure lung function before and after surgery. For diagnostic spirometry testing, desktop-based spirometers are frequently utilized in clinical environments like hospitals, clinics, and diagnostic laboratories.
Spirometers can also be used in therapeutic applications to track changes in lung function over time in order to evaluate the efficacy of treatment and modify it as necessary. For therapeutic spirometry testing, desktop-based spirometers are frequently utilized in clinical environments like hospitals, clinics, and diagnostic labs.
Hospitals
Clinics
Diagnostic Laboratories
Home Care Settings
The majority of desktop-based spirometer users are hospitals. In order to accurately diagnose respiratory disorders, desktop-based spirometers are frequently utilized in pulmonary function testing labs within hospitals Spirometers with a desktop design are used in clinics to diagnose respiratory illnesses and keep track of patients with long-term respiratory problems including COPD and asthma. Desktop-based spirometers are used in diagnostic labs to accurately diagnose respiratory illnesses and track patient lung function. Patients with chronic respiratory disorders are increasingly being monitored for lung function in home care settings using desktop-based spirometers. This permits prompt actions to avoid hospitalizations and early diagnosis of exacerbations.
North America
Europe
Asia Pacific
Middle East and Africa
South America
Due to the high prevalence of respiratory illnesses and the region's established healthcare infrastructure, desktop-based spirometers constitute a substantial market in North America. Due to government attempts to promote respiratory health, rising healthcare costs, and increasing demand for cutting-edge spirometry equipment, the United States is the region's largest market. Another sizable market for desktop-based spirometers is the Europe region. Due to the high prevalence of respiratory disorders in the area, healthcare organizations are purchasing cutting-edge spirometry equipment to enhance patient outcomes. Italy, France, Germany, the United Kingdom, and Germany are important markets in this area. Due to the rising frequency of respiratory disorders and rising healthcare costs, the Asia-Pacific region is anticipated to experience the fastest growth in the market for desktop-based spirometers.
Global Desktop-Based Spirometer Market Key Players:
CareFusion Corporation
CHEST M.I., Inc.
Cosmed srl
Futuremed America Inc.
MGC Diagnostics Corporation
ndd Medical Technologies, Inc.
NIHON KOHDEN CORPORATION
Schiller AG
Medical International Research
Vitalograph
Welch Allyn
SDI Diagnostics
Fukuda Sangyo Co., Ltd.
Vyaire Medical, Inc.
Chapter 1. Desktop-Based Spirometer Market – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. Desktop-Based Spirometer Market – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2023 - 2030
2.3.2. Impact on Supply – Demand
Chapter 3. Desktop-Based Spirometer Market – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. Desktop-Based Spirometer Market - Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. Desktop-Based Spirometer Market - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. Desktop-Based Spirometer Market - By Technology
6.1 Volume Measurement
6.2 Flow Measurement
6.3 Peak Flow Measurement
Chapter 7. Desktop-Based Spirometer Market - By Application
7.1 Diagnostic Applications
7.2 Therapeutic Applications
Chapter 8. Desktop-Based Spirometer Market - By End-User
8.1 Hospitals
8.2 Clinics
8.3 Diagnostic Laboratories
8.4 Home Care Settings
Chapter 9. Desktop-Based Spirometer Market - By Region
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Rest of the World
Chapter 10. Desktop-Based Spirometer Market - Key Players
10.1 CareFusion Corporation
10.2 CHEST M.I., Inc.
10.3 Cosmed srl
10.4 Futuremed America Inc.
10.5 MGC Diagnostics Corporation
10.6 ndd Medical Technologies, Inc.
10.7 NIHON KOHDEN CORPORATION
10.8 Schiller AG
10.9 Medical International Research
10.10 Vitalograph
10.11 Welch Allyn
10.12 SDI Diagnostics
10.13 Fukuda Sangyo Co., Ltd.
10.14 Vyaire Medical, Inc.
2500
4250
5250
6900
Frequently Asked Questions
The Global Desktop-Based Spirometer Market was estimated to be worth USD 484.9 Million in 2022 and is projected to reach a value of USD 884.31 Million by 2030, growing at a fast CAGR of 7.8% during the forecast period 2023-2030.
The Global Desktop-Based Spirometer Market is driven by the Increasing prevalence of respiratory diseases, Rising healthcare expenditure, and increasing awareness about lung health.
The Segments under the Global Desktop-Based Spirometer Market by the application are Diagnostic Applications and Therapeutic Applications.
China, Japan, South Korea, Singapore, and India are the most dominating countries in the Asia Pacific region for the Global Desktop-Based Spirometer Market.
CareFusion Corporation, CHEST M.I., Inc., and Cosmed srl are the three major leading players in the Global Desktop-Based Spirometer Market.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.